A study to assess the effect of palonosetron in preventing propofol pai
Not Applicable
- Conditions
- ASA 1 and ASA 2 patients
- Registration Number
- JPRN-UMIN000050665
- Lead Sponsor
- Bangalore Medical College and Research Institute
- Brief Summary
100 patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients refusing to participate in the study. Patients inability to verbally express the severity of pain. Patients with ischemic heart disease, previous myocardial infarction, congestive heart failure, congenital long QT syndrome. Patients with electrolyte abnormalities. Patients with hepatic and renal dysfunction. Patients with chronic alcohol abuse and patients on antipsychotic drugs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the effect of pre-treatment with intravenous palonosetron in preventing pain on propofol injection.
- Secondary Outcome Measures
Name Time Method To evaluate the safety profile associated with the use of Palonosetron.